Literature DB >> 1973256

Prion dementia without characteristic pathology.

J Collinge1, F Owen, M Poulter, M Leach, T J Crow, M N Rossor, J Hardy, M J Mullan, I Janota, P L Lantos.   

Abstract

Gerstmann-Sträussler syndrome (GSS) was diagnosed in a family with presenile dementia by prion protein gene analysis. Extensive histological examination of the brain of an affected individual from this family showed no characteristic features of GSS or Creutzfeldt-Jakob disease (CJD). Thus "spongiform encephalopathy" (GSS or CJD) cannot always be excluded on neuropathological grounds in an individual dying of a dementing condition, and the true prevalence of these diseases is likely to be underestimated. Screening by prion protein gene analysis will help to determine the full clinical and neuropathological phenotype in familial cases. This observation may be relevant to the assessment of possible transmission of bovine spongiform encephalopathy to man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973256     DOI: 10.1016/0140-6736(90)91518-f

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  46 in total

Review 1.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

2.  Research on familial Creutzfeldt-Jakob disease (FCJD) resulting in presymptomatic testing: implications for the Human Genome Project.

Authors:  Janet E Ulm; Cindy L Vnencak-Jones; Patrick Bosque
Journal:  J Genet Couns       Date:  1993-03       Impact factor: 2.537

3.  Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.

Authors:  Silvio M Zanata; Marilene H Lopes; Adriana F Mercadante; Glaucia N M Hajj; Luciana B Chiarini; Regina Nomizo; Adriana R O Freitas; Ana L B Cabral; Kil S Lee; Maria A Juliano; Elizabeth de Oliveira; Saul G Jachieri; Alma Burlingame; Lan Huang; Rafael Linden; Ricardo R Brentani; Vilma R Martins
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system.

Authors:  T Kitamoto; K Doh-ura; T Muramoto; M Miyazono; J Tateishi
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 5.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

6.  Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease.

Authors:  H A Kretzschmar; T Kitamoto; J Doerr-Schott; P Mehraein; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases.

Authors:  J Collinge; M Poulter; M B Davis; M Baraitser; F Owen; T J Crow; A E Harding
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

Review 8.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

9.  Prion protein gene analysis in three kindreds with fatal familial insomnia (FFI): codon 178 mutation and codon 129 polymorphism.

Authors:  R Medori; H J Tritschler
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

10.  Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

Authors:  J Chapman; P Brown; L G Goldfarb; A Arlazoroff; D C Gajdusek; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.